AMWL: Buy at $32.03 Profit Target at $40.04

American Well Corp aka Amwell is a virtual medicine consulting company. This helps especially during COVID where social distancing is promoted. This is a higher risk IPO base setup but is setting up very well. The first day low was not undercut. There is a 15% deep base and Sales is greater than 50% for the few quarters. Fundamental analysis below:

Quarterly Sales
Sep19: +22%
Dec19: +58%
Mar20: +60%
Jun20: +94%


Yearly EPS
2018: -0.24
2019: -0.39

The market is still in uncertain waters but more towards bullish territory. Once IXIC hits 1.5% on greater than previous day volume I would be more certain of jumping into the market. Institutional sponsorship has not been reported for this stock yet.